These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 11797712)

  • 1. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS
    Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
    [No Abstract]   [Full Text] [Related]  

  • 2. Legal overview of likely FDA regulation of Internet promotion.
    Scheineson MJ
    Food Drug Law J; 1996; 51(4):697-716. PubMed ID: 11797736
    [No Abstract]   [Full Text] [Related]  

  • 3. A global view of the First Amendment constraints of FDA.
    Carver KH
    Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459
    [No Abstract]   [Full Text] [Related]  

  • 4. Marketing health care products on the Internet: a proposal for updated federal regulations.
    Green K
    Am J Law Med; 1998; 24(2-3):365-86. PubMed ID: 9702278
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium.
    Garbutt BJ; Hofmann ME
    Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoting functional foods and nutraceuticals on the Internet.
    Taylor SE; Feld HJ
    Food Drug Law J; 1999; 54(3):423-51. PubMed ID: 11797707
    [No Abstract]   [Full Text] [Related]  

  • 7. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
    Pinco RG; Rubin PD
    Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
    [No Abstract]   [Full Text] [Related]  

  • 8. Surfing the Net in shallow waters: product liability concerns and advertising on the Internet.
    Moberg MA; Wood JW; Dorfman HL
    Food Drug Law J; 1998; 53(2):213-24. PubMed ID: 10346682
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM
    Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating drug promotion on the Internet.
    Bannon L
    Food Drug Law J; 1999; 54(4):599-621. PubMed ID: 11824457
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.
    Reichertz PS
    Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
    Allen MC
    Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of the Federal Trade Commission in advertising health products and services.
    Daynard M
    J Am Coll Dent; 2004; 71(2):24-6. PubMed ID: 15347100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 17. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ
    Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325
    [No Abstract]   [Full Text] [Related]  

  • 18. How should FDA regulate prescription drug promotion on the Internet?
    Opderbeck DW
    Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal guidelines to health services marketing: issues & checklists.
    Berning RK
    J Health Care Mark; 1983; 3(2):47-9. PubMed ID: 10261799
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.